Antiangiogenesis in haematological malignancies
作者： William W. Li , Michelle Hutnik , Gerald Gehr
DOI: 10.1111/J.1365-2141.2008.07372.X
关键词: Vascular endothelial growth factor 、 Vascular endothelial growth factor A 、 Bone marrow 、 Cancer cell 、 Bevacizumab 、 Angiogenesis 、 Cancer research 、 Adjunctive treatment 、 Immunology 、 Bortezomib 、 Biology
摘要: … followed by a 10-d rest period (21 d cycle) Mantle cell lymphoma – second line 12/2006 (USA) 1·3 mg/m 2 iv 3- to 5-second bolus twice weekly for 2 weeks followed by a 10-d rest …
elsevier.com
core.ac.uk 
sci-hub.se 参考文章(79)
Francis J. Giles, The emerging role of angiogenesis inhibitors in hematologic malignancies. Oncology. ,vol. 16, pp. 23- 29 ,(2002)
A. R. Perez-Atayde, S. E. Sallan, U. Tedrow, J. Folkman, S. Connors, E. Allred, Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. American Journal of Pathology. ,vol. 150, pp. 815- 821 ,(1997)
Alvaro Aguayo, Elihu Estey, Hagop Kantarjian, Taghi Mansouri, Cristi Gidel, Michael Keating, Francis Giles, Zeev Estrov, Bart Barlogie, Maher Albitar, Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. ,vol. 94, pp. 3717- 3721 ,(1999) , 10.1182/BLOOD.V94.11.3717
Walter Fiedler, Ullrich Graeven, Süleyman Ergün, Sandra Verago, Nerbil Kilic, Marcus Stockschläder, Dieter K. Hossfeld, Vascular Endothelial Growth Factor, a Possible Paracrine Growth Factor in Human Acute Myeloid Leukemia Blood. ,vol. 89, pp. 1870- 1875 ,(1997) , 10.1182/BLOOD.V89.6.1870
A.M. Martelli, P.L. Tazzari, C. Evangelisti, F. Chiarini, W.L. Blalock, A.M. Billi, L. Manzoli, J.A. McCubrey, L. Cocco, Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Current Medicinal Chemistry. ,vol. 14, pp. 2009- 2023 ,(2007) , 10.2174/092986707781368423
Jerry W. Hussong, George M. Rodgers, Paul J. Shami, Evidence of increased angiogenesis in patients with acute myeloid leukemia Blood. ,vol. 95, pp. 309- 313 ,(2000) , 10.1182/BLOOD.V95.1.309
M. Wang, R. Knight, M. Dimopoulos, D. Siegel, S. V. Rajkumar, T. Facon, Z. Yu, J. Zeldis, M. Olesnyckyj, D. M. Weber, Comparison of lenalidomide in combination with dexamethasone to dexamethasone alone in patients who have received prior thalidomide in relapsed or refractory multiple myeloma Journal of Clinical Oncology. ,vol. 24, pp. 7522- 7522 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.7522
Timothy Browder, Jan Palmblad, Judah Folkman, Angiogenesis research: guidelines for translation to clinical application. Thrombosis and Haemostasis. ,vol. 86, pp. 23- 33 ,(2001) , 10.1055/S-0037-1616197
Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber, William Novotny, None, Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nature Reviews Drug Discovery. ,vol. 3, pp. 391- 400 ,(2004) , 10.1038/NRD1381
Teresa Padró, Sandra Ruiz, Ralf Bieker, Horst Bürger, Martin Steins, Joachim Kienast, Thomas Büchner, Wolfgang E. Berdel, Rolf M. Mesters, Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. ,vol. 95, pp. 2637- 2644 ,(2000) , 10.1182/BLOOD.V95.8.2637